Latest Market News

Orezone Gold Corporation has clarified that it has not received any government request for equity participation in its Bomboré Gold Mine and will resume trading on the ASX. The company also provided updates on its mine expansion and production outlook.

Lumos Diagnostics has secured a significant follow-on contract with Aptatek Biosciences to push forward the development of an innovative in-home monitoring device for Phenylketonuria (PKU), a rare genetic disorder. This next phase aims to bring the FDA Breakthrough Device-designated PheCheck™ closer to clinical trials and commercial readiness.

Amaero Ltd has locked in a five-year exclusive agreement to supply spherical refractory and titanium alloy powders to Titomic, bolstering advanced manufacturing capabilities for defense and aerospace sectors.

Titomic Limited and Amaero Ltd have entered a five-year exclusive agreement to supply high-quality titanium and refractory powders, bolstering cold spray additive manufacturing for defense and aerospace sectors.

Clime Investment Management has reported a strong FY25 profit turnaround, posting $2.1 million pretax and amortisation profit and declaring a fully franked dividend. The company outlines ambitious growth and margin targets for FY26 amid strategic restructuring and technology investments.

Dateline Resources has secured $25 million in an institutional placement to accelerate exploration and development at its Colosseum Gold-REE Project in California, backed by strong U.S. government support and promising new targets.

The ASX has suspended trading in six companies starting 1 September 2025 due to late lodgement of mandatory periodic reports. The suspension may be lifted quickly if reports are filed promptly.

Lumos Diagnostics, backed by BARDA, is set to begin a pivotal pediatric clinical study to extend the use of its rapid respiratory infection test, FebriDx, to children aged 2–12 in U.S. CLIA-waived settings, potentially unlocking a $1 billion market.

Canyon Resources’ Definitive Feasibility Study confirms Minim Martap as a major bauxite project with a 33% ore reserve increase and robust economics, targeting production start in early 2026.

Imricor Medical Systems has taken a significant step toward U.S. market entry by submitting its Vision-MR Diagnostic Catheter for FDA 510(k) approval, complementing its recent NorthStar system filing. These moves aim to establish a fully integrated MRI-guided cardiac ablation platform.

Horizon Gold has successfully completed its renounceable entitlement issue, raising nearly $7 million including a full shortfall placement, positioning the company for further development at its Gum Creek Gold Project.

Dundee Precious Metals has received court sanction for its recommended acquisition of Adriatic Metals, paving the way for a scheme of arrangement expected to take effect on 3 September 2025. The transaction will result in Adriatic shares being cancelled and DPM’s listing on the ASX as a foreign exempt entity.